141 related articles for article (PubMed ID: 26970119)
1. Precision oncology: a strategy we were not ready to deploy.
Fojo T
Semin Oncol; 2016 Feb; 43(1):9-12. PubMed ID: 26970119
[No Abstract] [Full Text] [Related]
2. Perspective: The precision-oncology illusion.
Prasad V
Nature; 2016 Sep; 537(7619):S63. PubMed ID: 27602743
[No Abstract] [Full Text] [Related]
3. Re: Use of archived specimens in evaluation of prognostic and predictive biomarkers.
Ahern TP; Hankinson SE
J Natl Cancer Inst; 2011 Oct; 103(20):1558-9; author reply 1559-60. PubMed ID: 21917608
[No Abstract] [Full Text] [Related]
4. Statistical Methods for Establishing Personalized Treatment Rules in Oncology.
Ma J; Hobbs BP; Stingo FC
Biomed Res Int; 2015; 2015():670691. PubMed ID: 26446492
[TBL] [Abstract][Full Text] [Related]
5. Application of pharmacogenomics in supportive oncology: a patient journey.
Nguyen DG; Morris SA; Patel JN
Pharmacogenomics; 2022 Oct; 23(15):807-811. PubMed ID: 36239145
[No Abstract] [Full Text] [Related]
6. Editorial: (Pharmaco)Metabolomics in Drug Discovery and Individualisation of Treatment.
Katsila T; Patrinos GP
Curr Pharm Des; 2017; 23(14):2027. PubMed ID: 28701139
[No Abstract] [Full Text] [Related]
7. Personalized medicine and economic evaluation in oncology: all theory and no practice?
Garattini L; Curto A; Freemantle N
Expert Rev Pharmacoecon Outcomes Res; 2015; 15(5):733-8. PubMed ID: 26289733
[TBL] [Abstract][Full Text] [Related]
8. Nucleoside analogs: ready to enter the era of precision medicine?
Ciccolini J; Serdjebi C; Le Thi Thu H; Lacarelle B; Milano G; Fanciullino R
Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):865-77. PubMed ID: 27218825
[TBL] [Abstract][Full Text] [Related]
9. Clinical implementation of pharmacogenetics.
García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
[TBL] [Abstract][Full Text] [Related]
10. Health: Make precision medicine work for cancer care.
Rubin MA
Nature; 2015 Apr; 520(7547):290-1. PubMed ID: 25877189
[No Abstract] [Full Text] [Related]
11. Cancer pharmacogenomics.
Paugh SW; Stocco G; McCorkle JR; Diouf B; Crews KR; Evans WE
Clin Pharmacol Ther; 2011 Sep; 90(3):461-6. PubMed ID: 21796115
[TBL] [Abstract][Full Text] [Related]
12. Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials.
Hyman DM; Solit DB; Arcila ME; Cheng DT; Sabbatini P; Baselga J; Berger MF; Ladanyi M
Drug Discov Today; 2015 Dec; 20(12):1422-8. PubMed ID: 26320725
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics in the age of personalized medicine.
Dickmann LJ; Ware JA
Drug Discov Today Technol; 2016; 21-22():11-16. PubMed ID: 27978982
[TBL] [Abstract][Full Text] [Related]
14. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
15. Translating Pharmacogenetics to Clinical Practice: Do Cytochrome P450 2D6 Ultrarapid Metabolizers Need Higher Atomoxetine Doses?
de Leon J
J Am Acad Child Adolesc Psychiatry; 2015 Jul; 54(7):532-4. PubMed ID: 26088654
[No Abstract] [Full Text] [Related]
16. Evaluating the Utility of a 'N-of-1' Precision Cancer Medicine Strategy: The Case for 'Time-to-Subsequent-Disease Progression'.
Markman M; Kramer K; Alvarez RH; Weiss GJ; Ahn E; Daneker GW
Oncology; 2016; 91(6):299-301. PubMed ID: 27705967
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics in cancer therapy - 8 years of experience at the Institute for Oncology and Radiology of Serbia.
Cavic M; Krivokuca A; Boljevic I; Brotto K; Jovanovic K; Tanic M; Filipovic L; Zec M; Malisic E; Jankovic R; Radulovic S
J BUON; 2016; 21(5):1287-1295. PubMed ID: 27837635
[TBL] [Abstract][Full Text] [Related]
18. Precision in cancer pharmacogenomics.
Kyrochristos ID; Baltagiannis EG; Mitsis M; Roukos DH
Pharmacogenomics; 2020 Apr; 21(5):311-316. PubMed ID: 32242500
[No Abstract] [Full Text] [Related]
19. Molecular Targets in Advanced Therapeutics of Cancers: The Role of Pharmacogenetics.
Abubakar MB; Gan SH
Oncology; 2016; 91(1):3-12. PubMed ID: 27233906
[TBL] [Abstract][Full Text] [Related]
20. [Translational research in clinical oncology: challenges and opportunities].
Díaz-Rubio García E
An R Acad Nac Med (Madr); 2008; 125(1):105-20; discussion 121-2. PubMed ID: 18777846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
